Every one of those 2 sits in a single category, regulation. Of the tracked stories, 1 of 2 also mention Bob Ferguson, the most common co-covered peer. Across a 10-day span, the pace is roughly 1.4 stories per week. Each story carries 2 original sources on average, compared with 3.1 for the broader beat in this window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Washington State
Every one of those 2 sits in a single category, regulation. Of the tracked stories, 1 of 2 also mention Bob Ferguson, the most common co-covered peer. Across a 10-day span, the pace is roughly 1.4 stories per week. Each story carries 2 original sources on average, compared with 3.1 for the broader beat in this window. Their average consequence score of 6.5 runs above the beat's 6.4 for that window. We currently track 2 Legal stories that mention Washington State, published between March 16, 2026 and March 25, 2026.
Stories tracked
2
Per week
1.4
Sources per story
2
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 496 Legal stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Washington State. Shared-story counts are live from our verified record — not editorial picks.
Governor Bob Ferguson has signed SHB 1155 into law, effectively voiding nearly all noncompete agreements for employees and independent contractors in Washington starting June 30, 2027. The legislation includes retroactive provisions and mandates that employers provide written notice to affected individuals by October 2027.
Washington state has enacted legislation to facilitate the distribution of its mifepristone stockpile to healthcare providers, ensuring continued access amidst ongoing federal legal uncertainty. The law removes administrative barriers that previously complicated the transfer of state-purchased medication to private and public clinics.